The US Food and Drug Administration has approved a new sunscreen ingredient, adding bemotrizinol to its list of permitted active ingredients. It is the first time a new sunscreen ingredient has been cleared in roughly two decades, with the previous approvals dating back to the 1990s. Because that list had not been updated in about 20 years, the decision is being closely watched in the dermatology world and among those who advocate for sun protection.
Although the ingredient is new to the United States, it is not brand new as a substance. What makes it notable is how it works compared with existing options. Bemotrizinol is classed as a chemical sunscreen, but it has been engineered to behave differently from other chemical filters. Rather than penetrating deeply into the skin, it is designed to sit on top of it while still doing the job of preventing ultraviolet rays from causing damage.
That distinction matters because of how the two main families of sunscreen behave. Mineral sunscreens, which contain components such as zinc oxide, sit on the surface of the skin and work as a reflector, but many people dislike the white cast they can leave. Chemical sunscreens, by contrast, are absorbed into the skin and work by absorbing UV rays, raising concerns because studies have shown some can be absorbed to the point of entering the bloodstream.
According to the medical guidance shared on the topic, no signs of harm have been seen in human studies from that absorption, but it could be problematic at high levels. The appeal of the newly approved ingredient is that it aims to combine the strengths of both approaches, offering the protection of a chemical sunscreen while staying on the surface rather than deeply penetrating the skin.
Another advantage highlighted is its stability. Bemotrizinol is described as photostable, which means it does not break down as quickly over time. Many sunscreens lose effectiveness as they degrade, which can leave the wearer exposed to UV rays. Because the new ingredient holds up better, it can technically last longer on the skin and provide broader spectrum coverage, a quality that has helped drive interest in it.
The path to approval involved a lengthy review. The change was proposed in December 2025, followed by a period of public input, and it reached the market through a process known as generally recognized as safe. Regulators relied on a large body of research, including extensive clinical studies that were reviewed by the FDA and produced by the manufacturer, before the ingredient was permitted to reach store shelves.
Doctors used the announcement to repeat basic sun-safety advice. An SPF of 30 already blocks about 97 percent of UV rays, and going higher brings diminishing returns, so the most important factor is choosing a product that is easy to reapply. Reapplying every two hours, and especially after heavy sweating or swimming, is considered key. The stakes are significant, with experts noting that as few as five sunburns in a lifetime can double a person's chances of developing melanoma.